Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132246) titled 'Study on the Application and Anti-inflammatory Mechanism of Liposomal Bupivacaine in Postoperative Analgesia of Patients with Hip Fracture' on Sept. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Changzhou Jintan First Peopie's Hospital
Condition:
Postoperative pain following hip fracture in elderly patients
Intervention:
LB:Intraoperative fascia iliaca plane block with liposomal bupivacaine
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-11
Target Sample Size: LB:20;BUP:20;
Countries of Recruitment:
China
To know more, visit https://...